Healthy Living & Work
Diseases and chronic disorders related to our lifestyle are on the increase. We must, therefore, look at health and care in a different way, and combine prevention and treatment. At TNO, we’re working on social and technological innovations that help people make choices for better health and greater participation in society.
Promoting health with innovations for self-determination
‘We want to help people make the right choices for their health, employability, and productivity. It's not easy when you see what we have to deal with every day. For example, working longer in a healthy way, an often busy or intense living environment, and an intensive lifestyle,’ says TNO's Peter van Dijken.
Together with government agencies, knowledge institutes, and companies, we develop technological and social innovations that improve health and professional employability. In this way, they contribute to:
- a healthy, vital, and productive population
- lower healthcare costs
- more economic growth
Healthy Living active in 6 domains
The Healthy Living unit is active within 6 expertise groups:
- Risk Analysis for Products In Development (RAPID)
- Microbiology & Systems Biology Expertise Group
- Metabolic Health Research Expertise Group
- Child Health Expertise Group
- Work Health Technology Expertise Group
- Sustainable Productivity & Employability
We’re good at identifying major future developments and interventions relevant to these domains. Within the domains, we develop knowledge and expertise in health, health technology, and customised health interventions. Health interventions are methods and technologies that can be used when someone's health is at risk.
For example, we’re contributing to the transformation of youth healthcare through digitalisation. We’re developing an online platform that provides guidelines for youth healthcare and gives parents access to the professionals and advice they need to make the right choices. In addition, we measure and monitor stress and exposure to harmful substances in everyday life.
This leads us to collective public health strategies, personalised intervention strategies, and evidence-based health interventions, especially for the work environment. This creates a basis for interventions and assistive technology to improve both prevention and participation.
Health interventions
We want to significantly reduce the failure rate and thus the development costs of much-needed new drugs. We do this by innovating in the preclinical and clinical phases of drug development.
We also help the general public and professionals make healthy choices by collecting data on health and risks at a personal level. We convert them into valuable information, which we use to provide proactive, tailor-made advice. This personal information supports structural behavioural changes and a healthier lifestyle. We’re convinced that a change in lifestyle is the cure of the future for many diseases.
How do we improve the quality of digital healthcare?
Healthcare is digitalising at a rapid pace. This allows you to collect a lot of data and gain insight into genetic, lifestyle, and environmental factors. We develop useful, safe, and reliable applications that meet everyone's need for personalised healthcare. Privacy is a prerequisite.
We develop interpretations and predictive models of the personal health data for reliable advice and personalised interventions. We’re trying to improve personalised digital health with practical pilots.
Expert groups
Get inspired
TNO proves method for effective pediatric drug development
Safe and effective drug dosing for young children come with their own challenges. Up to the age of 18, a child’s metabolism can change significantly. And in the first two years of life, those ontogenic differences can be rapid and dramatic. TNO published its findings from the first drug disposition (mass balance/metabolite profiling) study to conclusively prove that microtracing with accelerator mass spectrometry (AMS) is an effective way to collect clinical data in these young patients. This AMS technology can also be the key to building up more data on drug interventions in pregnant and lactating mothers.


TNO's view of 2030: 50% reduction in lifestyle-related diseases
We look ahead to 2030 and find out, among other things, how we can offer people a healthy environment and with a healthier lifestyle.


Translational models TNO excel in preclinical research


Public Private Partnership Arla Food Ingredients and Danone


International Women’s Day 2022
Today on International Women’s Day we celebrate the success and achievements of women in science for breaking down barriers and challenging the status quo. Get to know some of TNO’s women contributing to a sustainable society every day.

